Literature DB >> 30173264

The role of immunohistochemistry in the diagnosis and management of synovial sarcoma.

Daniel Laurenţiu Pop1, Roxana Folescu, Bogdan Nicolae Deleanu, Mihaela Iacob, Dinu Vermeşan, Radu Prejbeanu, Daniel Claudiu Maliţa, Horia George Hărăguş, Bogdan Cătălin Ciupe, Carmen Lăcrămioara Zamfir, Gheorghe Nodiţi.   

Abstract

Synovial sarcoma (SS) is a malignant soft tissue tumor representing 5-10% of all soft tissue sarcomas. Most synovial sarcomas are found at the extremities, especially in the lower limbs. A 28-year-old female presented at the Department of Plastic and Reconstructive Surgery, "Dr. Pius Brînzeu" Clinical Hospital, Timişoara, Romania, for evaluation of a mass located in the anterior region of the elbow. Imagistic, histological and immunohistochemically evaluations established the diagnosis of monophasic spindle cell SS G2. Block excision of the tumor with oncological safety margins was performed followed by total elbow arthroplasty. The patient then received radio- and chemotherapy. The case was followed-up at regular intervals for local recurrence and metastases and was free of symptoms at two years. Early diagnosis of SS, multimodal therapies and performing an arthroplasty of the elbow allowed the patient to resume daily activities. The unpredictable evolution requires regular follow-up for a long period of time.

Entities:  

Mesh:

Year:  2018        PMID: 30173264

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  1 in total

Review 1.  Large giant cell tumor of the posterior iliac bone - an atypical location. A case report and literature review.

Authors:  Cosmin Ioan Faur; Daniel Laurenţiu Pop; Andrei Gheorghe Marius Motoc; Roxana Folescu; Mirela Loredana Grigoraş; Daniela Gurguş; Carmen Lăcrămioara Zamfir; Mihaela Iacob; Dinu Vermeşan; Bogdan Nicolae Deleanu; Horia George Hărăguş; Daniel Claudiu Maliţa; Ahmed Abu-Awwad; Ion Lucian Ghiga; Mariana Tudoran
Journal:  Rom J Morphol Embryol       Date:  2020       Impact factor: 1.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.